Recent discussions and reports highlight concerns over the safety and misuse of GLP1-ra medications, particularly semaglutide (Ozempic/Wegovy). Scams related to these drugs have increased significantly. Issues arise when combining Ozempic with bariatric surgery, leading to potential complications. Lawsuits related to Ozempic have emerged, and retailers are experiencing a sales boost as people switch to smaller sizes due to the drug. However, there are warnings against the misuse of Ozempic and Wegovy for quick weight loss, emphasizing their intended use in treating obesity or diabetes.
🚨 THE MISUSE OF OZEMPIC AND WEGOVY IS LIFE-THREATENING National Medical Director of NHS England, Stephen Powis, warns that Ozempic and Wegovy should be used for treating obesity or diabetes, not as quick fixes for achieving a “beach body.” Despite a July 2023 survey showing… https://t.co/X6F2muu4XQ
Ozempic drives more demand for smaller clothes, WSJ reports https://t.co/6IzjXR6QhZ
Zepbound vs Ozempic/Wegovy (Side note: pleasantly surprised Januvia is holding on…to something) https://t.co/Bc8Dyy88DR https://t.co/IYAxev5B3g
Lots of folks are taking Semaglutide (Ozempic) to quickly lose weight. But it has side effects. One of the side effects is “Ozempic Face”. This is what it looks like 👇 https://t.co/RQQsGzq77n
Dangers of taking Ozempic to get ‘beach body ready’ revealed by top doc https://t.co/0a6oPdYAiA https://t.co/VivwH3rBGw
Ozempic is fueling the hunt for smaller clothes as retailers see a nascent sales boost fueled by people switching to smaller sizes https://t.co/Ik6DVCksVR https://t.co/Ik6DVCksVR
The Ozempic lawsuits have begun... This week's health and nutrition news by @garytaubes and me https://t.co/OT5SEVXtzV https://t.co/QpUcSRAX4s
Ozempic with bariatric surgery is a nasty mix. Bariatric surgery shrinks the stomach. Ozempic slows it down. That's a recipe for disaster. They should be contraindicated, but they aren't. Sad story but it won't be the last. https://t.co/VeVeqQRY8q
The number of Ozempic and Wegovy scams has grown by 183% so far this year https://t.co/jbQ3yJgfdR
our primary discussion with @jillianmichaels yesterday was about safety of GLP1-ra, especially semaglutide (#ozempic/#wegovy). Hard to cite during a discussion like that so here are data from meta-analyses of actual RCTs ¥ real world data for reassurance. @DrNadolsky https://t.co/wIGTUZRi17